FDA Warning Letter — Aurolife Pharma, LLC
The FDA took a Warning Letter action against Aurolife Pharma, LLC on October 16, 2020 (Dayton, NJ). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Aurolife Pharma, LLC
- Date
- October 16, 2020
- Fiscal Year
- 2021
- Product Type
- Drugs
- Center
- CDER
- Location
- Dayton, NJ (United States)